Monday 16th November, the second day of London Global Cancer Week and the first full day of meetings, has set the stage for the week to come. For the time being, and for many people in the world,. the phrase ‘The Big C’ no longer refers to cancer but to the Coronavirus or ‘COVID-19’. Following a filmed welcome by Dame Cally Palmer CBE, National Cancer Director NHS England, at 8 a.m. the first session – The COVID-19 pandemic: An African perspective – got straight to the heart of the matter.
Chaired by : Professor Frank Chinegwundoh, Consultant Urological Surgeon, Barts Health NHS Trust and AORTIC Vice-President Europe , and hosted by the African Organisation for Research and Training in Cancer (AORTIC), the three speakers Dr Abubakar Mohammed Bello, Head and Chief Consultant, Clinical and Radiation Oncologist, National Hospital, Abuja, Nigeria, Dr Yehoda M. Martei, MD – Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania and Dr Kwanele Asante, Chairperson, Ministerial Advisory Committee on Cancer Prevention and Control, Republic of South Africa described in detail how the impact of this year’s pandemic has cost the lives of cancer patients though delay and reduction of access to care. “The right to life of cancer patients have been undermined by COVID-19” Dr Asante explained, adding “the fact that we are even having this conversation is important. “
This hour long session was followed by two sessions hosted by the World Health Organisation that demonstrated to good effect the value of nations coming together in common purpose. Leading speakers from IARC, IAEA and WHO lined up to show a united front in the fight against cancer. “Today is about partnership . We will have to continue together” Dr Bente Mikkelsen, WHO Director for NCDS told the audience, although there were few illusions that the current situation is propitious. Lack of meaningful funding globally for cancer has been a long standing obstacle “We cannot wait longer to invest in cancer “ Dr Minghui Ren (WHO Assistant Director General NCDs) insisted; a view echoed by Dr Mikkelsen “We have seen huge underinvestment in NCDs , including cancer”. As a result 25 out of 53 African countries still do not have radiotherapy machines Eduardo Zubizarreta (IAEA) reported and only 35% of African patients needing radiotherapy receive the treatment. And, as Geraldine Arios de Goebl (IAEA) observed, “Cancer doesn’t stop for Covid”
In the second WHO session (“WHO Global Initiatives in Cancer: platforms for accelerated action ) the focus turned to WHO’s recently announced strategies on childhood cancers and cervical cancer. In her thoughtful presentation Princess Nono Simelala reminded the attendees that with cervical cancer there are pockets of underserved populations even in high income countries and she urged that all countries should move to HPV testing to prevent cervical cancers. For the first time ever, the world has committed to eliminate a cancer and, with the Launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer due to take place the following day (Tuesday 17 November) there was no danger of the meeting not recognising the historic significance of that decision. “ The elimination of cervical cancer,” declared Cherian Varghese WHO Coordinator, Management of NCDs “ is the pathfinder to all cancer control “
The afternoon session, for the first time in five years not being held in the hallowed halls of the Royal Society of Medicine, got back on track. Titled The impact of COVID-19 on cancer management in low and middle income countries, it arranged its big guns to face the pandemic’s incursion for the benefit of its paying audience Its stellar roster of speakers included Ms Isabel Mestres, (City Cancer Challenge), Dr Hannah Tharmalingam, Vice-President, Clinical Oncol(Royal College of Radiologists, London) Dr Partha Basu, (Head, Screening Group IARC) , Dr Ophira Ginsburg, New York University, USA) Professor Karen Canfell (Cancer Council, New South Wales) Professor Mary Gospodarowicz, (Toronto, Canada), and Dr Manjit Dosanjh, (Honorary CERN Staff, European Organization for Nuclear Research (CERN)), with Professor Bente Mikkelsen (WHO) and Dr May Abdel-Wahab, (IAEA) gamely staying online after the morning’s session.
Keeping an eye on the continued underinvestment for cancer by governments despite the SDG goals Professor. Richard Sullivan wondered whether pandemic preparedness would crowd out cancer? Pointing out that the Incidence of COVID-19 is higher in cancer patients compared to general population Professor Warren Phipps (Ugandan Cancer Institute) described the sterling efforts that had been made to protect UCI staff through a WhatsApp-based screening tool developed in collaboration with the Fred Hutchinson Institute. Based at National Center for Radiotherapy and Nuclear Medicine, Korle-Bu Teaching Hospital, Accra, Ghana Dr Verna Vanderpuye’s presentation was reported by one listener to be ‘wonderful, emotional and an inspiration to listen to.’
Tuesday’s events promise to be equally fulfilling. The day begins early (at 8 a.m.) in India with the CReDO workshop Shaping the future of global oncology research. At 9.30 a.m. 9.30 am there will be a major event celebrating the Year of the Nurse -The Global Power of Oncology Nursing – hosted by the UK Oncology Nursing Society and the Royal College of Nuirsing. The day’s events will close with the meeting Research and Treatment of Paediatric Cancers During Covid-19: Global Perspectives hosted by INCTR and GCPA-Europe/SIDCER. All Tuesday’s meetings offer free registration.
